In addition, Arenillas and colleagues reported that metabolic syndrome is associated with resistance to clot lysis after tissue plasminogen activator therapy, and stated that the presence of metabolic syndrome can hamper the arterial recanalization process [34], which is suggestive of a poor stroke prognosis. This evidence concerns the gene PLAT and stroke disorder.